| NCT ID | NCT02041481 |
| Title | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | City of Hope Medical Center, National Cancer Institute (NCI), Novartis |
| Indications | |
| Therapies | |
| Age Groups: | adult |